Indirect DNA Readout on the Protein Side: Coupling between Histidine Protonation, Global Structural Cooperativity, Dynamics, and DNA Binding of the Human Papillomavirus Type 16 E2C Domain

Journal of Molecular Biology

Volumn 388, Issue 2, 2009, Pages 327-344

  Eliseo, Tommaso ^a   Sánchez, Ignacio E ^b   Nadra, Alejandro D ^a,b   Dellarole, Mariano ^b   Paci, Maurizio ^a   de Prat Gay, Gonzalo ^b   Cicero, Daniel O ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b FUNDACIÓN INSTITUTO LELOIR   (Argentina)

Author keywords

DNA sequence recognition; histidine; indirect readout; papillomavirus E2 protein; protein dynamics

Indexed keywords

AMIDE; DIMER; HISTIDINE; PROTEIN E2C; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BETA CHAIN; CARBOXY TERMINAL SEQUENCE; DIMERIZATION; DNA CONFORMATION; DNA SEQUENCE; HUMAN PAPILLOMAVIRUS TYPE 16; ISOTHERMAL TITRATION CALORIMETRY; MOLECULAR DYNAMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PH; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTON TRANSPORT; REGULATORY MECHANISM;

HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

EID: 64049119694     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.03.013     Document Type: Article

References (79)

1. Lesser D.R., Kurpiewski M.R., and Jen-Jacobson L. The energetic basis of specificity in the EcoRI endonuclease-DNA interaction. Science 250 (1990) 776-786
2. Luscombe N.M., Laskowski R.A., and Thornton J.M. Amino acid-base interactions: a three-dimensional analysis of protein-DNA interactions at an atomic level. Nucleic Acids Res. 29 (2001) 2860-2874
3. Lundback T., van Den Berg S., and Hard T. Sequence-specific DNA binding by the glucocorticoid receptor DNA-binding domain is linked to a salt-dependent histidine protonation. Biochemistry 39 (2000) 8909-8916
4. Deleeuw L., Tchernatynskaia A.V., and Lane A.N. Thermodynamics and specificity of the Mbp1-DNA interaction. Biochemistry 47 (2008) 6378-6385
5. Bradshaw E.M., Sanford D.G., Luo X., Sudmeier J.L., Gurard-Levin Z.A., Bullock P.A., and Bachovchin W.W. T antigen origin-binding domain of simian virus 40: determinants of specific DNA binding. Biochemistry 43 (2004) 6928-6936
6. Bergqvist S., Williams M.A., O'Brien R., and Ladbury J.E. Heat capacity effects of water molecules and ions at a protein-DNA interface. J. Mol. Biol. 336 (2004) 829-842
7. Holmbeck S.M., Dyson H.J., and Wright P.E. DNA-induced conformational changes are the basis for cooperative dimerization by the DNA binding domain of the retinoid X receptor. J. Mol. Biol. 284 (1998) 533-539
8. Wikstrom A., Berglund H., Hambraeus C., van den Berg S., and Hard T. Conformational dynamics and molecular recognition: backbone dynamics of the estrogen receptor DNA-binding domain. J. Mol. Biol. 289 (1999) 963-979
9. Zhu L., Hu J., Lin D., Whitson R., Itakura K., and Chen Y. Dynamics of the Mrf-2 DNA-binding domain free and in complex with DNA. Biochemistry 40 (2001) 9142-9150
10. Kalodimos C.G., Boelens R., and Kaptein R. A residue-specific view of the association and dissociation pathway in protein-DNA recognition. Nat. Struct. Biol. 9 (2002) 193-197
11. Jarymowycz V.A., and Stone M.J. Fast time scale dynamics of protein backbones: NMR relaxation methods, applications, and functional consequences. Chem. Rev. 106 (2006) 1624-1671
12. Okamura H., Makino K., and Nishimura Y. NMR dynamics distinguish between hard and soft hydrophobic cores in the DNA-binding domain of PhoB and demonstrate different roles of the cores in binding to DNA. J. Mol. Biol. 367 (2007) 1093-1117
13. Rippin T.M., Freund S.M., Veprintsev D.B., and Fersht A.R. Recognition of DNA by p53 core domain and location of intermolecular contacts of cooperative binding. J. Mol. Biol. 319 (2002) 351-358
14. Ferreiro D.U., Lima L.M., Nadra A.D., Alonso L.G., Goldbaum F.A., and de Prat Gay G. Distinctive cognate sequence discrimination, bound DNA conformation, and binding modes in the E2 C-terminal domains from prototype human and bovine papillomaviruses. Biochemistry 39 (2000) 14692-14701
15. Zhang Y., Xi Z., Hegde R.S., Shakked Z., and Crothers D.M. Predicting indirect readout effects in protein-DNA interactions. Proc. Natl Acad. Sci. USA 101 (2004) 8337-8341
16. Hegde R.S. The papillomavirus E2 proteins: structure, function, and biology. Annu. Rev. Biophys. Biomol. Struct. 31 (2002) 343-360
17. de Prat Gay G., Gaston K., and Cicero D.O. The papillomavirus E2 DNA binding domain. Front. Biosci. 13 (2008) 6006-6021
18. Sanchez I.E., Dellarole M., Gaston K., and de Prat Gay G. Comprehensive comparison of the interaction of the E2 master regulator with its cognate target DNA sites in 73 human papillomavirus types by sequence statistics. Nucleic Acids Res. 36 (2008) 756-769
19. Lefstin J.A., and Yamamoto K.R. Allosteric effects of DNA on transcriptional regulators. Nature 392 (1998) 885-888
20. Laine O., Streaker E.D., Nabavi M., Fenselau C.C., and Beckett D. Allosteric signaling in the biotin repressor occurs via local folding coupled to global dampening of protein dynamics. J. Mol. Biol. 381 (2008) 89-101
21. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348 (2003) 518-527
22. Bosch F.X., Sanjosé S., Castellsagué X., Moreno V., and Muñoz N. Epimediology of human papillomavirus infections and associations with cervical cancer: new opportunities for prevention. In: Saveria Campo M. (Ed). Papillomavirus Research: From Natural History to Vaccines and Beyond chapt. 3 (2006), Caisreir Academic Press, Wymondham 19-40
23. D'Souza G., Kreimer A.R., Viscidi R., Pawlita M., Fakhry C., Koch W.M., et al. Case-control study of human papillomavirus and oropharyngeal cancer. N. Engl. J. Med. 356 (2007) 1944-1956
24. Cohen J. Public health. High hopes and dilemmas for a cervical cancer vaccine. Science 308 (2005) 618-621
25. Hegde R.S. Papillomavirus proteins and their potential as drug design targets. Future Med. 1 (2006) 795-810
26. Kalantari M., and Bernard H.-U. Gene expression of papillomaviruses. In: Saveria Campo M. (Ed). Papillomavirus Research: From Natural History to Vaccines and Beyond chapt. 4 (2006), Caisreir Academic Press, Wymondham 41-52
27. McBride A.A., Romanczuk H., and Howley P.M. The papillomavirus E2 regulatory proteins. J. Biol. Chem. 266 (1991) 18411-18414
28. Parish J.L., Kowalczyk A., Chen H.T., Roeder G.E., Sessions R., Buckle M., and Gaston K. E2 proteins from high- and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death. J. Virol. 80 (2006) 4580-4590
29. Brown C., Kowalczyk A.M., Taylor E.R., Morgan I.M., and Gaston K. p53 represses human papillomavirus type 16 DNA replication via the viral E2 protein. Virol. J. 5 (2008) 5
30. Nadra A.D., Eliseo T., Mok Y.K., Almeida C.L., Bycroft M., Paci M., et al. Solution structure of the HPV-16 E2 DNA binding domain, a transcriptional regulator with a dimeric beta-barrel fold. J. Biomol. NMR 30 (2004) 211-214
31. Cicero D.O., Nadra A.D., Eliseo T., Dellarole M., Paci M., and de Prat Gay G. Structural and thermodynamic basis for the enhanced transcriptional control by the human papillomavirus strain-16 E2 protein. Biochemistry 45 (2006) 6551-6560
32. Hegde R.S., and Androphy E.J. Crystal structure of the E2 DNA-binding domain from human papillomavirus type 16: implications for its DNA binding-site selection mechanism. J. Mol. Biol. 284 (1998) 1479-1489
33. Hegde R.S., Grossman S.R., Laimins L.A., and Sigler P.B. Crystal structure at 1.7 Å of the bovine papillomavirus-1 E2 DNA-binding domain bound to its DNA target. Nature 359 (1992) 505-512
34. Hegde R.S., Wang A.F., Kim S.S., and Schapira M. Subunit rearrangement accompanies sequence-specific DNA binding by the bovine papillomavirus-1 E2 protein. J. Mol. Biol. 276 (1998) 797-808
35. Kim S.S., Tam J.K., Wang A.F., and Hegde R.S. The structural basis of DNA target discrimination by papillomavirus E2 proteins. J. Biol. Chem. 275 (2000) 31245-31254
36. Liang H., Petros A.M., Meadows R.P., Yoon H.S., Egan D.A., Walter K., et al. Solution structure of the DNA-binding domain of a human papillomavirus E2 protein: evidence for flexible DNA-binding regions. Biochemistry 35 (1996) 2095-2103
37. Bussiere D.E., Kong X., Egan D.A., Walter K., Holzman T.F., Lindh F., et al. Structure of the E2 DNA-binding domain from human papillomavirus serotype 31 at 2.4 Å. Acta Crystallogr. Sect. D 54 (1998) 1367-1376
38. Hooley E., Fairweather V., Clarke A.R., Gaston K., and Brady R.L. The recognition of local DNA conformation by the human papillomavirus type 6 E2 protein. Nucleic Acids Res. 34 (2006) 3897-3908
39. Dell G., Wilkinson K.W., Tranter R., Parish J., Leo Brady R., and Gaston K. Comparison of the structure and DNA-binding properties of the E2 proteins from an oncogenic and a non-oncogenic human papillomavirus. J. Mol. Biol. 334 (2003) 979-991
40. Veeraraghavan S., Mello C.C., Androphy E.J., and Baleja J.D. Structural correlates for enhanced stability in the E2 DNA-binding domain from bovine papillomavirus. Biochemistry 38 (1999) 16115-16124
41. Wetzler, D. E., Gallo, M., Melis, R., Tommaso, E., Nadra, A. D., Ferreiro, D. U., et al. (2009). A strained DNA binding helix is conserved for site recognition, folding nucleation, and conformational modulation. Biopolymers, in press. doi:10.1002/bip.21146.
42. Bochkarev A., Barwell J.A., Pfuetzner R.A., Bochkareva E., Frappier L., and Edwards A.M. Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein, EBNA1, bound to DNA. Cell 84 (1996) 791-800
43. Ferreiro D.U., Sanchez I.E., and de Prat Gay G. The transition state for protein-DNA recognition. Proc. Natl Acad. Sci. USA 105 (2008) 10797-10802
44. Ferreiro D.U., Dellarole M., Nadra A.D., and de Prat Gay G. Free energy contributions to direct readout of a DNA sequence. J. Biol. Chem. 280 (2005) 32480-32484
45. Falconi M., Santolamazza A., Eliseo T., de Prat Gay G., Cicero D.O., and Desideri A. Molecular dynamics of the DNA-binding domain of the papillomavirus E2 transcriptional regulator uncover differential properties for DNA target accommodation. FEBS J. 274 (2007) 2385-2395
46. Falconi M., Oteri F., Eliseo T., Cicero D.O., and Desideri A. MD simulations of papillomavirus DNA-E2 protein complexes hints at a protein structural code for DNA deformation. Biophys. J. 95 (2008) 1108-1117
47. Dellarole M., Sanchez I.E., Freire E., and de Prat Gay G. Increased stability and DNA site discrimination of "single chain" variants of the dimeric beta-barrel DNA binding domain of the human papillomavirus E2 transcriptional regulator. Biochemistry 46 (2007) 12441-12450
48. Whitten S.T., Garcia-Moreno E.B., and Hilser V.J. Local conformational fluctuations can modulate the coupling between proton binding and global structural transitions in proteins. Proc. Natl Acad. Sci. USA 102 (2005) 4282-4287
49. Wiseman T., Williston S., Brandts J.F., and Lin L.N. Rapid measurement of binding constants and heats of binding using a new titration calorimeter. Anal. Biochem. 179 (1989) 131-137
50. Ellis K.J., and Morrison J.F. Buffers of constant ionic strength for studying pH-dependent processes. Methods Enzymol. 87 (1982) 405-426
51. Baker B.M., and Murphy K.P. Evaluation of linked protonation effects in protein binding reactions using isothermal titration calorimetry. Biophys. J. 71 (1996) 2049-2055
52. Lima L.M., and de Prat Gay G. Conformational changes and stabilization induced by ligand binding in the DNA-binding domain of the E2 protein from human papillomavirus. J. Biol. Chem. 272 (1997) 19295-19303
53. Bose K., Yoder N.C., Kumar K., and Baleja J.D. The role of conserved histidines in the structure and stability of human papillomavirus type 16 E2 DNA-binding domain. Biochemistry 46 (2007) 1402-1411
54. 15N-labeled proteins. J. Magn. Reson. B 113 (1996) 236-247
55. 15N NMR spectroscopy of hydrogen-bonding interactions in the active site of serine proteases: evidence for a moving histidine mechanism. Biochemistry 25 (1986) 7751-7759
56. Woodward C., Simon I., and Tüchsen E. Hydrogen exchange and the dynamic structure of proteins. Mol. Cell. Bichem. 48 (1982) 135-160
57. 15N relaxation data exclusively. J. Biomol. NMR 6 (1995) 153-162
58. Farrow N.A., Zhang O., Forman-Kay J.D., and Kay L.E. Comparison of the backbone dynamics of a folded and an unfolded SH3 domain existing in equilibrium in aqueous solution. Biochemistry 34 (1995) 868-878
59. Peng J.W., and Wagner G. Frequency spectrum of NH bonds in eglinc from spectral density mapping at multiple fields. Biochemistry 34 (1995) 16733-16752
60. Bai Y., Sosnick T.R., Mayne L., and Englander S.W. Protein folding intermediates: native-state hydrogen exchange. Science 269 (1995) 192-197
61. Ferreiro D.U., and de Prat Gay G. A protein-DNA binding mechanism proceeds through multi-state or two-state parallel pathways. J. Mol. Biol. 331 (2003) 89-99
62. Mok Y.K., de Prat Gay G., Butler P.J., and Bycroft M. Equilibrium dissociation and unfolding of the dimeric human papillomavirus strain-16 E2 DNA-binding domain. Protein Sci. 5 (1996) 310-319
63. de Prat Gay G., Nadra A.D., Corrales-Izquierdo F.J., Alonso L.G., Ferreiro D.U., and Mok Y.K. The folding mechanism of a dimeric beta-barrel domain. J. Mol. Biol. 351 (2005) 672-682
64. Ogata K., Kanei-Ishii C., Sasaki M., Hatanaka H., Nagadoi A., Enari M., et al. The cavity in the hydrophobic core of Myb DNA-binding domain is reserved for DNA recognition and trans-activation. Nat. Struct. Biol. 3 (1996) 178-187
65. Dupureur C.M., and Dominguez Jr. M.A. The PD...(D/E)XK motif in restriction enzymes: a link between function and conformation. Biochemistry 40 (2001) 387-394
66. Cordier F., Hartmann B., Rogowski M., Affolter M., and Grzesiek S. DNA recognition by the Brinker repressor-an extreme case of coupling between binding and folding. J. Mol. Biol. 361 (2006) 659-672
67. Dyson H.J., and Wright P.E. Coupling of folding and binding for unstructured proteins. Curr. Opin. Struct. Biol. 12 (2002) 54-60
68. Spolar R.S., and Record Jr. M.T. Coupling of local folding to site-specific binding of proteins to DNA. Science 263 (1994) 777-784
69. Mok Y.K., Bycroft M., and de Prat Gay G. The dimeric DNA binding domain of the human papillomavirus E2 protein folds through a monomeric intermediate which cannot be native-like. Nat. Struct. Biol. 3 (1996) 711-717
70. Wetzler D.E., Castano E.M., and de Prat Gay G. A quasi-spontaneous amyloid route in a DNA binding gene regulatory domain: the papillomavirus HPV16 E2 protein. Protein Sci. 16 (2007) 744-754
71. Keskin O., Jernigan R.L., and Bahar I. Proteins with similar architecture exhibit similar large-scale dynamic behavior. Biophys. J. 78 (2000) 2093-2106
72. Maguid S., Fernandez-Alberti S., and Echave J. Evolutionary conservation of protein vibrational dynamics. Gene 422 (2008) 7-13
73. Maguid S., Fernandez-Alberti S., Parisi G., and Echave J. Evolutionary conservation of protein backbone flexibility. J. Mol. Evol. 63 (2006) 448-457
74. Sim J., Ozgur S., Lin B.Y., Yu J.H., Broker T.R., Chow L.T., and Griffith J. Remodeling of the human papillomavirus type 11 replication origin into discrete nucleoprotein particles and looped structures by the E2 protein. J. Mol. Biol. 375 (2008) 1165-1177
75. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., and Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6 (1995) 277-293
76. Johnson B.A., and Blevins R.A. NMRView: a computer program for the visualization and analysis of NMR data. J. Biomol. NMR 4 (1994) 603-614
77. 15N NMR relaxation and chemical shift: conformational exchange in plastocyanin induced by histidine protonations. J. Am. Chem. Soc. 126 (2004) 753-765
78. 15N NMR relaxation measurements. Biochemistry 31 (1992) 4394-4406
79. 15N inverse detected heteronuclear NMR spectroscopy: application to staphylococcal nuclease. Biochemistry 28 (1989) 8972-8979